• Pages: 1-3
• First Published: 12 December 2023

• Pages: 4-5
• First Published: 12 December 2023

• Pages: 6-7
• First Published: 12 December 2023

• Pages: 8-22
• First Published: 20 November 2023

Impact of intragastric balloon therapy on NAFLD-related parameters in patients with obesity: A systematic review and meta-analysis.

• Pages: 23-38
• First Published: 25 October 2023

Comparison between ultrasound, the GALAD score, and glycomics to diagnose hepatocellular carcinoma.

DIAGNOSTIC TESTS: BILE-ACID DIARRHOEA

Open Access

oa

Prospective comparison of diagnostic tests for bile acid diarrhoea

Christian Borup,  Lars Vinter-Jensen,  Søren Peter German Jørgensen,  Signe Wildt,  Jesper Graff,  Tine Gregersen,  Anna Zaremba,  Trine Borup Andersen,  Camilla Nøjgaard,  Hans Bording Timm,  Antonin Lamazière,  Dominique Rainteau,  Svend Høime Hansen,  Jüri Johannes Rumessen,  Lars Kristian Munck, 

• Pages: 39-50
• First Published: 05 October 2023

Diagnostic performance of diagnostic tests for bile acid diarrhoea

• Abstract
• Full text
• PDF
• References
• Request permissions

DESIGN OF THE PHASE 3 MAESTRO PROGRAM

Open Access

oa

Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitis

Stephen A. Harrison,  Vlad Ratziu,  Quentin M. Anstee,  Mazen Noureddin,  Arun J. Sanyal,  Jörn M. Schattenberg,  Pierre Bedossa,  Mustafa R. Bashir,  David Schneider,  Rebecca Taub,  Meena Bansal,  Kris V. Kowdley,  Zobair M. Younossi,  Rohit Loomba, 

• Pages: 51-63
• First Published: 02 October 2023

This article relates to:

• Letter: Resmetirom for treatment of MASH with children and adolescents

  • Yong-Hai Zhou, 
  • Mohit Kehar, 
  • Nicholas Beng Hui Ng, 
  • Ming-Hua Zheng, 
  • Volume 60Issue 7Alimentary Pharmacology & Therapeutics
  • pages: 982-983
  • First Published online: August 30, 2024

• Abstract
• Full text
• PDF
• References
• Request permissions

SEGMENTAL HEALING IN ULCERATIVE COLITIS

no

The assessment of segmental healing by the Modified Mayo Endoscopic Score (MMES) complements the prediction of long-term clinical outcomes in patients with ulcerative colitis

Matthias Lenfant,  Bram Verstockt,  João Sabino,  Séverine Vermeire,  Marc Ferrante, 

• Pages: 64-70
• First Published: 16 October 2023

Current endoscopic scoring systems for ulcerative colitis do not consider the extent of mucosal inflammation. The modified Mayo endoscopic score (MMES) was developed to detect segmental endoscopic improvement. Patients with segmental endoscopic response showed superior long-term clinical outcome as compared to patients without endoscopic response.

• Abstract
• Full text
• PDF
• References
• Request permissions

LIVER DISEASE AFTER BONE MARROW TRANSPLANT

no

Hepatobiliary disease after bone marrow transplant: A cross-sectional study of 377 patients

Maria Gabriela Fernandes Dezan,  Lourianne Nascimento Cavalcante,  Hugo Rodrigues Carvalho Silva,  Alessandro de Moura Almeida,  Luiz Henrique dos Santos de Assis,  Tiago Thalles de Freitas,  Marco Aurélio Salvino de Araújo,  Helma Pinchemel Cotrim,  Andre Castro Lyra, 

• Pages: 71-79
• First Published: 13 October 2023

Frequency of hepatobiliary complications in BMT recipients, comparison of length of stay and death rates.

• Abstract
• Full text
• PDF
• References
• Request permissions

PROGNOSTIC IMPLICATION OF LIVER FAT IN NASH CIRRHOSIS

no

Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality

Sung Won Lee,  Daniel Q. Huang,  Ricki Bettencourt,  Veeral Ajmera,  Monica Tincopa,  Nabil Noureddin,  Maral Amangurbanova,  Harris Siddiqi,  Egbert Madamba,  Abdul M. Majzoub,  Tarek Nayfeh,  Nobuharu Tamaki,  Namiki Izumi,  Atsushi Nakajima,  Masato Yoneda,  Ramzan Idilman,  Mesut Gumussoy,  Digdem Kuru Oz,  Ayse Erden,  Rohit Loomba, 

• Pages: 80-88
• First Published: 15 November 2023

Correction(s) for this article

• Corrigendum

  • Volume 59Issue 3Alimentary Pharmacology & Therapeutics
  • pages: 427-427
  • First Published online: January 2, 2024

Low liver fat content in patients with burnt-out NASH-related significant fibrosis and cirrhosis is associated with an increase in hepatic decompensation, HCC and mortality.

• Abstract
• Full text
• PDF
• References
• Request permissions

CLOSTRIUM DIFFICILE IN IBD

no

Recent trends and risk factors associated with Clostridioides difficile infections in hospitalized patients with inflammatory bowel disease

Ellen J. Spartz,  Lauren C. DeDecker,  Kush M. Fansiwala,  Shaya Noorian,  Andrew R. Roney,  Shahrad Hakimian,  Jenny S. Sauk,  Po-Hung Chen,  Berkeley N. Limketkai, 

• Pages: 89-99
• First Published: 24 October 2023

Rates are higher in patients with UC than with CD and patients without IBD. Rates of CDI were increasing but have declined since 2015. CDI is associated with increased comorbidity, public insurance, urban teaching hospitals, and larger hospital size. CDI is associated with increased mortality.

• Abstract
• Full text
• PDF
• References
• Request permissions

OESOPHAGEAL INNERVATION

no

Superficial oesophageal mucosal innervation may contribute to severity of symptoms in oesophageal motility disorders

Akinari Sawada,  Mengyu Zhang,  Ahsen Ustaoglu,  Kornilia Nikaki,  Chung Lee,  Philip Woodland,  Etsuro Yazaki,  Shingo Takashima,  Masaki Ominami,  Fumio Tanaka,  Clorinda Ciafardini,  Fabio Nachman,  Andrés Ditaranto,  Joaquín Agotegaray,  Claudio Bilder,  Edoardo Savarino,  C. Prakash Gyawali,  Roberto Penagini,  Yasuhiro Fujiwara,  Daniel Sifrim, 

• Pages: 100-112
• First Published: 16 October 2023

Superficial oesophageal mucosal nerves were associated with severe dysphagia in patients with disorders of OGJ outflow.

• Abstract
• Full text
• PDF
• References
• Request permissions

OBETICHOLIC ACID IN LOW PHOSPHOLIPID-ASSOCIATED CHOLELITHIASIS SYNDROME

no

Obeticholic acid as a second-line treatment for low phospholipid-associated cholelithiasis syndrome

Pierre-Antoine Soret,  Sara Lemoinne,  Maxime Mallet,  Karima Ben Belkacem,  Olivier Chazouillères,  Christophe Corpechot, 

• Pages: 113-117
• First Published: 11 October 2023

Proof-of-concept study of obeticholic acid (OCA), a selective agonist of the farnesoid-X receptor (FXR), for the treatment of low phospholipid-associated cholelithiasis (LPAC) syndrome.

• Abstract
• Full text
• PDF
• References
• Request permissions

• Pages: 118-119
• First Published: 12 December 2023

• Pages: 120-121
• First Published: 12 December 2023

• Pages: 122-123
• First Published: 12 December 2023

• Pages: 124-125
• First Published: 12 December 2023

• Pages: 126-127
• First Published: 12 December 2023

• Pages: 128-129
• First Published: 12 December 2023

• Pages: 130-131
• First Published: 12 December 2023

• Pages: 132-133
• First Published: 12 December 2023

• Pages: 134-135
• First Published: 12 December 2023

• Pages: 136-137
• First Published: 12 December 2023

• Pages: 138-139
• First Published: 12 December 2023

• Pages: 140-141
• First Published: 12 December 2023

• Pages: 142-143
• First Published: 04 November 2023

• Page: 144
• First Published: 03 November 2023

• Page: 145
• First Published: 06 November 2023